Ofer Haviv
Chief Executive Officer chez EVOGENE LTD.
Fortune : - $ au 31/03/2024
Profil
Ofer Haviv is currently the President & Chief Executive Officer at Evogene Ltd., Chairman at Evofuel Ltd., Chairman at Evogene, Inc., Chairman at Lavie Bio Ltd., and Chairman at Biomica Ltd.
He previously worked as the Treasurer & Finance Director at Compugen Ltd.
Mr. Haviv completed his undergraduate degree at Tel-Aviv University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOGENE LTD
-.--% | 17/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Ofer Haviv
| Sociétés | Poste | Début |
|---|---|---|
| EVOGENE LTD. | Chief Executive Officer | 01/12/2004 |
| Evofuel Ltd. | Chairman | 01/01/2012 |
| Evogene, Inc. | Chairman | 01/01/2006 |
Biomica Ltd.
 Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Chairman | - |
| Lavie Bio Ltd. | Chairman | - |
Anciens postes connus de Ofer Haviv
| Sociétés | Poste | Fin |
|---|---|---|
| COMPUGEN LTD. | Director of Finance/CFO | - |
Formation de Ofer Haviv
| Tel-Aviv University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| EVOGENE LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Evofuel Ltd. | |
| Evogene, Inc. | |
| Lavie Bio Ltd. | |
Biomica Ltd.
Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Commercial Services |
